Memantine vs Trastuzumab

## Memantine vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Memantine** and **Trastuzumab**.

## Mechanism of Action

**Memantine**: Non-competitive NMDA receptor antagonist.

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Memantine — 60-80 hours; Trastuzumab — 28 days.

## Chemical Properties

**Molecular Formula**: Memantine — C12H21N; Trastuzumab — N/A.

**Molecular Weight**: Memantine — 179.3080 g/mol; Trastuzumab — N/A.

**Type**: Memantine — Small molecule; Trastuzumab — Antibody.